These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15047529)

  • 1. Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys.
    Sandhu P; Xu X; Bondiskey PJ; Balani SK; Morris ML; Tang YS; Miller AR; Pearson PG
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1272-80. PubMed ID: 15047529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma.
    Stone JA; Xu X; Winchell GA; Deutsch PJ; Pearson PG; Migoya EM; Mistry GC; Xi L; Miller A; Sandhu P; Singh R; deLuna F; Dilzer SC; Lasseter KC
    Antimicrob Agents Chemother; 2004 Mar; 48(3):815-23. PubMed ID: 14982770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.
    Balani SK; Xu X; Arison BH; Silva MV; Gries A; DeLuna FA; Cui D; Kari PH; Ly T; Hop CE; Singh R; Wallace MA; Dean DC; Lin JH; Pearson PG; Baillie TA
    Drug Metab Dispos; 2000 Nov; 28(11):1274-8. PubMed ID: 11038152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872).
    Hajdu R; Thompson R; Sundelof JG; Pelak BA; Bouffard FA; Dropinski JF; Kropp H
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2339-44. PubMed ID: 9371330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
    Wasan KM; Sivak O; Rosland M; Risovic V; Bartlett K
    J Pharm Sci; 2007 Jul; 96(7):1737-47. PubMed ID: 17080414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.
    Stone JA; Holland SD; Wickersham PJ; Sterrett A; Schwartz M; Bonfiglio C; Hesney M; Winchell GA; Deutsch PJ; Greenberg H; Hunt TL; Waldman SA
    Antimicrob Agents Chemother; 2002 Mar; 46(3):739-45. PubMed ID: 11850256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits.
    Groll AH; Gullick BM; Petraitiene R; Petraitis V; Candelario M; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2001 Feb; 45(2):596-600. PubMed ID: 11158761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic uptake of the novel antifungal agent caspofungin.
    Sandhu P; Lee W; Xu X; Leake BF; Yamazaki M; Stone JA; Lin JH; Pearson PG; Kim RB
    Drug Metab Dispos; 2005 May; 33(5):676-82. PubMed ID: 15716364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
    Balani SK; Woolf EJ; Hoagland VL; Sturgill MG; Deutsch PJ; Yeh KC; Lin JH
    Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.
    Tang-Liu DD; Richman JB; Lin P; Selim S
    Biopharm Drug Dispos; 1993 May; 14(4):313-24. PubMed ID: 8499582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspofungin: first approved agent in a new class of antifungals.
    Johnson MD; Perfect JR
    Expert Opin Pharmacother; 2003 May; 4(5):807-23. PubMed ID: 12740003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
    Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
    Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.
    Mattiuz E; Franklin R; Gillespie T; Murphy A; Bernstein J; Chiu A; Hotten T; Kassahun K
    Drug Metab Dispos; 1997 May; 25(5):573-83. PubMed ID: 9152596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
    Tan EY; Hartmann G; Chen Q; Pereira A; Bradley S; Doss G; Zhang AS; Ho JZ; Braun MP; Dean DC; Tang W; Kumar S
    Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.